Arnicare Leg Cramps ARNICA MONTANA, LACTIC ACID, L-, ZINC OXIDE 9 [hp_C]/1; 3 [hp_C]/1; 3 [hp_C]/1 Tablet, 11-count — NDC 0220-9073-06 (Billing 00220-9073-06)
This is a package of 11 tablets of Arnicare Leg Cramps ARNICA MONTANA, LACTIC ACID, L-, ZINC OXIDE 9 [hp_C]/1; 3 [hp_C]/1; 3 [hp_C]/1 Tablet from Boiron, marketed since Jun 2018 and currently FDA-listed. It is the main listing for this product, which comes in 2 package sizes.
NDC database record
One package, one record: these facts belong to NDC 0220-9073-06 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 0220 labeler · 9073 product · 06 package
- Package marketed since
- Jun 15, 2018
- Sample package
- No — commercial package
- Listing certified through
- Dec 31, 2026
- Barcode (UPC-A, from the NDC)
- 3 0220907306 0
- FDA record last changed
- Jul 24, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 8, 2026
- FDA label on DailyMed · label index refreshed Oct 8, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 8, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 8, 2026
Clinical
Arnicare Leg Cramps is an oral tablet marketed as a homeopathic product. It contains arnica montana, lactic acid, and zinc oxide in homeopathic potencies. In homeopathic practice, arnica montana is traditionally used for muscle soreness and discomfort, while lactic acid and zinc oxide appear in various homeopathic formulations. Homeopathic products are not evaluated by the FDA for effectiveness and are marketed based on homeopathic tradition rather than clinical evidence.
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Oct 8, 2026
- FDA label on DailyMed · label index refreshed Oct 8, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 9, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 00220-9073-06 You're viewing this Main listing | 11 TABLET in 1 TUBE | 2018-06-15 | — | Active |
| 00220-9073-90 0220-9073-90 | 33 TUBE in 1 PACKAGE / 11 TABLET in 1 TUBE | 2018-06-15 | — | Active |
Pack size FAQ
What quantity is in this package?
How does this package differ from NDC 00220-9073-90?
What NDC number is used to bill for this package of Arnicare Leg Cramps ARNICA MONTANA, LACTIC ACID, L-, ZINC OXIDE 9 [hp_C]/1; 3 [hp_C]/1; 3 [hp_C]/1 Tablet?
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Arnicare Leg Cramps 9 [hp_C]/1; 3 [hp_C]/1; 3 [hp_C]this 00220-9073-06 | Boiron | 11 tablets | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 8, 2026
- FDA Orange Book · refreshed Oct 3, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Oct 3, 2026
What it looks like
Where does this data come from?
- FDA label on DailyMed · label index refreshed Oct 8, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII 2968PHW8QP
A weak organic acid derived from citrus fruits or made through fermentation. It works as a buffer to control pH, a preservative to extend shelf life, and a flavoring agent in medications.
-
UNII LX22YL083G
A simple sugar derived from corn or other sources. It acts as a filler to give the medicine bulk and volume, and as a sweetener to improve taste in oral medications.
-
UNII J2B2A4N98G
Lactose is a natural sugar derived from milk. In medications, it serves as a filler and binder to add bulk and help hold tablet or capsule ingredients together during manufacturing.
-
UNII 24RS0A988O
Lemon is a citrus fruit extract used as a natural flavoring agent and acidulant to add tart taste and help preserve medicines while improving their palatability.
-
UNII 70097M6I30
Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
-
UNII 059QF0KO0R
Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
6 inactive ingredients listed in the exact product block matched to this NDC.
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Oct 8, 2026
- FDA openFDA NDC Directory · synced Oct 8, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Boiron labeler code 00220
- Arnicare Arnica ARNICA MONTANA 9 [hp_C]/1 Tablet NDC 0220-9059-04
- ColdCalm Kids STRYCHNOS NUX-VOMICA SEED, PULSATILLA VULGARIS, ONION, PHYTOLACCA AMERICANA ROOT, POTASSIUM DICHROMATE, GELSEMIUM SEMPERVIRENS ROOT, EUPATORIUM PERFOLIATUM FLOWERING TOP, APIS MELLIFERA, 3 [hp_C]/1; 6 [hp_C]/1; 3 [hp_C]/1; 15 [hp_C]/1; 3 [hp_C]/1; 6 [hp_C]/1; 6 [hp_C]/1 Liquid NDC 0220-9060-09
- Chestal Adult Pellets ANTIMONY POTASSIUM TARTRATE,BRYONIA ALBA ROOT, PROTORTONIA CACTI, DROSERA ROTUNDIFOLIA WHOLE, IPECAC, RUMEX CRISPUS ROOT, SPONGIA OFFICINALIS SKELETON, ROASTED, PULSATILLA VULGARIS WHOLE, LOBARIA PULMONARIA 3 [hp_C]/1; 3 [hp_C]/1; 6 [hp_C]/1; 3 [hp_C]/1; 3 [hp_C]/1; 3 [hp_C]/1; 3 [hp_C]/1; 6 Pellet NDC 0220-9065-41
- Chestal Kids Pellets ANTIMONY POTASSIUM TARTRATE, BRYONIA ALBA ROOT, PROTORTONIA CACTI,DROSERA ROTUNDIFOLIA WHOLE, IPECAC, PULSATILLA VULGARIS WHOLE, RUMEX CRISPUS ROOT,SPONGIA OFFICINALIS SKELETON, ROASTED, LOBARIA PULMONARIA 3 [hp_C]/1; 6 [hp_C]/1; 3 [hp_C]/1; 3 [hp_C]/1; 3 [hp_C]/1; 3 [hp_C]/1; 6 [hp_C]/1; 3 Pellet NDC 0220-9066-41
- Chestal Cough and Cold SOLANUM DULCAMARA TOP, FERRUM PHOSPHORICUM, GOLDENSEAL, POTASSIUM DICHROMATE, STRYCHNOS NUX-VOMICA SEED 5 [hp_C]/mL; 9 [hp_C]/mL; 9 [hp_C]/mL; 9 [hp_C]/mL; 9 [hp_C]/mL Syrup NDC 0220-9067-28
- Chestal Childrens Cough and Cold SOLANUM DULCAMARA TOP, FERRUM PHOSPHORICUM, GOLDENSEAL, POTASSIUM DICHROMATE, STRYCHNOS NUX-VOMICA SEED 5 [hp_C]/mL; 9 [hp_C]/mL; 9 [hp_C]/mL; 9 [hp_C]/mL; 9 [hp_C]/mL Syrup NDC 0220-9068-28
- ColicComfort ACTIVATED CHARCOAL, COPPER, CITRULLUS COLOCYNTHIS FRUIT 5 [hp_C]/1; 5 [hp_C]/1; 9 [hp_C]/1 Liquid NDC 0220-9074-09
- ARNICARE ARTHRITIS ARNICA MONTANA, HARPAGOPHYTUM PROCUMBENS ROOT, HARPAGOPHYTUM ZEYHERI ROOT 1 [hp_X]/g; 1 [hp_X]/g; 1 [hp_X]/g Cream NDC 0220-9077-63
- Cyclease Cramps BLACK COHOSH, CITRULLUS COLOCYNTHIS FRUIT PULP, ESIUM PHOSPHATE, DIBASIC TRIHYDRATE 6 [hp_C]/1; 6 [hp_C]/1; 6 [hp_C]/1 Tablet NDC 0220-9078-04
- Arnicare Leg Cramps ARNICA MONTANA WHOLE, COPPER, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, STRYCHNOS NUX-VOMICA SEED, PASSIFLORA INCARNATA TOP, CLAVICEPS PURPUREA SCLEROTIUM 6 [hp_C]/1; 9 [hp_C]/1; 4 [hp_C]/1; 6 [hp_C]/1; 3 [hp_X]/1; 6 [hp_C]/1 Tablet NDC 0220-9079-04
- Cyclease PMS ESTRONE, SODIUM CHLORIDE, SEPIA OFFICINALIS JUICE 15 [hp_C]/1; 12 [hp_C]/1; 12 [hp_C]/1 Tablet NDC 0220-9081-04
- Cyclease Menopause ARNICA MONTANA WHOLE, BLACK COHOSH, NITROGLYCERIN, LACHESIS MUTA VENOM, SANGUINARIA CANADENSIS ROOT 4 [hp_C]/1; 4 [hp_C]/1; 5 [hp_C]/1; 4 [hp_C]/1; 4 [hp_C]/1 Tablet NDC 0220-9082-04
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 8, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
🎯 Indications and Usage ▾
Uses* temporarily relieves minor muscle pain from cramps, stiffness, and muscular fatigue due to prolonged exercise and physical activity
⏱️ Dosage and Administration ▾
Directions Adults and children 12 years of age and older: Chew 1 tablet in the mouth immediately prior, during, and after physical activity every hour until symptoms improve, up to 10 tablets a day. Children under 12 years of age: Not recommended.
🧪 Active Ingredient ▾
Active Ingredients** Arnica montana 9C HPUS (6.67 mg) Sarcolacticum acidum 3C HPUS (6.67 mg) Zincum oxydatum 3C (6.67 mg)
🧪 Inactive Ingredients ▾
citric acide, dextrose, lactose, magnesium stearate, natural lemon flavor
🎯 Purpose ▾
Purpose* Arnica montana 9C HPUS ... Temporarily relieves minor pain, stiffness & muscle soreness due to overexertion Sarcolacticum acidum 3C HPUS ... Relieves muscle fatigue after prolonged exercise & muscle cramping Zincum oxydatum 3C ... Relieves muscle cramping
📄 Stop Use and Ask a Doctor If ▾
Stop use and ask a doctor if symptoms persist for more than 3 days or worsen, new symptoms occur, or if redness or swelling is present. These could be signs of a serious condition.
🤰 If Pregnant or Breast-Feeding ▾
If pregnant or breast-feeding, ask a health professional before use.
📄 Keep Out of Reach of Children ▾
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
📄 Questions or Comments ▾
Quesions or comments? Arnicare.com BoironUSA.com [email protected] 1-800-BOIRON-1 (1-800-264-7661) Made in France Distributed by: Boiron Inc. Newtown Square, PA 19073-3267
📄 Package Label / Principal Display Panel ▾
label label label Label box tube
About this NDC listing & data coverage
About homeopathic listings
Arnicare Leg Cramps ARNICA MONTANA, LACTIC ACID, L-, ZINC OXIDE 9 [hp_C]/1; 3 [hp_C]/1; 3 [hp_C]/1 TABLET is listed under the homeopathic marketing category. An NDC listing in this category does not by itself establish FDA approval, and FDA does not evaluate homeopathic products for effectiveness. This page reports the listing data as published.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |